ML-004 in Adolescents and Adults With Autism Spectrum Disorders (ASD)
Summary
- Eligibility
- for people ages 12-45 (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedcompletion around
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- MapLight Therapeutics
- ID
- NCT05081245
- Phase
- Phase 2 Autism Research Study
- Study Type
- Interventional
- Participants
- Expecting 150 study participants
- Last Updated